The IVF process, utilizing PESA and ICSI, was tailored to address the husband’s obstructive azoospermia, enabling the couple to achieve a successful and healthy pregnancy.
Chandigarh, December 30, 2024 – Jindal IVF, a renowned institute in Assisted Reproductive Technology (ART) and In Vitro Fertilization (IVF), has celebrated another landmark achievement with the successful delivery of a baby following a complex case involving obstructive azoospermia and a high-risk pregnancy.
A 35-year-old couple approached Jindal IVF after facing significant fertility challenges. The husband was diagnosed with obstructive azoospermia, and initial consultations led them to consider Intrauterine Insemination (IUI) with donor sperm. However, Jindal IVF’s team, led by Dr. Sheetal Jindal, Senior Consultant and IVF-PGT Specialist, proposed an alternative approach using the husband’s own sperm.
To retrieve sperm, the medical team employed Percutaneous Epididymal Sperm Aspiration (PESA)—a specialized procedure that extracts sperm directly from the epididymis in cases of obstructive azoospermia. The retrieved sperm was then used for Intracytoplasmic Sperm Injection (ICSI) to fertilize eggs collected from the wife’s ovaries. Despite financial constraints that limited the couple’s options for embryo pooling, the process resulted in a single high-quality embryo.
The embryo transfer yielded unexpected results, as the single embryo split after implantation, resulting in a Monochorionic Diamniotic (MCDA) twin pregnancy, where identical twins share a single placenta. While this condition is rare and associated with significant risks such as Twin-to-Twin Transfusion Syndrome (TTTS), the team at Jindal IVF closely monitored the pregnancy, ensuring the best possible outcome.
During the pregnancy, the team identified severe complications requiring critical intervention. Due to the unequal distribution of blood supply between the twins, cord coagulation of one twin’s umbilical cord was performed to preserve the health of the other twin. This intervention allowed the pregnancy to progress successfully to 34 weeks, culminating in the birth of a healthy baby.
“This case underscores the transformative potential of advanced reproductive technologies and personalized care,” said Dr. Sheetal Jindal. “The resilience and trust of our patients, combined with the expertise and dedication of our team, made this achievement possible. Our commitment to leveraging cutting-edge techniques continues to bring hope and joy to families facing infertility.”
The parents expressed heartfelt gratitude to the Jindal IVF team for their unwavering support and expertise. “We are beyond thankful to Dr. Jindal and the entire team for making our dream of parenthood a reality. Despite the challenges, their care and dedication never faltered,” shared the couple.
With over 30 years of experience in Assisted Reproductive Technology, Jindal IVF remains at the forefront of innovation, offering compassionate and tailored solutions to couples navigating infertility challenges. This success story is a testament to the institute’s mission of transforming lives through science and care.
